Cite
HARVARD Citation
Gisondi, P. et al. (2020). Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. British journal of dermatology. pp. 397-398. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gisondi, P. et al. (2020). Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. British journal of dermatology. pp. 397-398. [Online].